Sign in

CIK 0001896212

  • Emerging growth company

CDT Equity Inc.

Sign in to watch
Ticker
CDT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
873272543
Phone
+1 646-491-9132
Business address
4851 TAMIAMI TRAIL NORTH, SUITE 200, NAPLES, FL, 34103
Former names
CONDUIT PHARMACEUTICALS INC., Murphy Canyon Acquisition Corp.

Securities

  • CDT Common Stock Nasdaq
  • CDTTW Warrant Nasdaq
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 2 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-10-23 Regan Andrew 10% owner Other acquisition +499,616 499,618
2026-10-22 Regan Andrew 10% owner Other acquisition +1,347,616 1,347,619
2026-08-28 Regan Andrew Chief Executive Officer Other acquisition +543,683 569,322
2026-08-28 Regan Andrew Chief Executive Officer Sale −29 569,322
2026-08-28 Regan Andrew Chief Executive Officer Option exercise · Pre-Funded Warrants −543,683 $0.00 $54 0
2026-08-28 Regan Andrew Chief Executive Officer Other acquisition +5,436,830 5,693,223
2026-08-28 Regan Andrew Chief Executive Officer Sale −290 5,692,933
2026-08-28 Regan Andrew Chief Executive Officer Option exercise · Pre-Funded Warrants −5,436,830 $0.00 $544 0
2026-07-30 Regan Andrew Chief Executive Officer Other acquisition · Pre-Funded Warrants +5,436,830 $0.00 $544 543,683
2026-07-30 Regan Andrew Chief Executive Officer Other acquisition · Pre-Funded Warrants +5,436,830 $0.00 $544 5,436,830
2026-06-18 Taylor Mark Andrew 10% owner Sale −5,000 $0.71 $4K 1,464,711
2026-06-18 Taylor Mark Andrew 10% owner Sale −1,464,711 $1.44 $2.1M 0
2026-06-18 Taylor Mark Andrew 10% owner Sale −5,000 $0.75 $4K 593,289
2026-06-18 Taylor Mark Andrew 10% owner Sale −593,289 $1.40 $829K 0
2026-05-13 Regan Andrew Chief Executive Officer Grant or award +100,000 $1.90 $190K 256,393
2026-03-24 Regan Andrew Chief Executive Officer Grant or award +147,401 156,393
2026-03-24 Regan Andrew Chief Executive Officer Conversion · Pre-Funded Warrants −147,401 $0.00 $15 0
2026-03-17 Taylor Mark Andrew 10% owner Other acquisition +51,420,358 51,700,014
2026-03-17 Taylor Mark Andrew 10% owner Other disposition · Pre-Funded Warrants −51,161,318 0
2026-02-19 Taylor Mark Andrew 10% owner Other disposition −46,902 279,656

Page 1 of 5 · 90 trades